1. Introduction {#sec1}
===============

Neurofibroma (NF) is a benign slow growing tumour of the peripheral nerve sheath. It may occur as an isolated sporadic lesion or may be associated with neurofibromatosis type 1, which is also known as von Recklinghausen\'s disease. Neurofibroma of the maxillary sinus is an exceedingly rare tumour. We report a case of right maxillary sinus neurofibroma and literature review of this rare condition.

2. Case {#sec2}
=======

We present a case of 70-year-old gentleman who was referred to the ENT department with a one-year history of right maxillary sinus mass. He presented with significant proptosis, ptosis, and limitation in abduction of the right eye. He also complained of right sided facial pain with no history of epistaxis or nasal congestion.

Patient has a past medical history of multiple neurofibromas which had been excised. He is otherwise fit and healthy.

Craniofacial MRI scan has shown a large lesion within the maxillary sinus itself which completely fills and extends into the inferior orbit, cavernous sinus, and pterygopalatine fossa as shown in Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}.

Biopsy of the right maxillary mass revealed cellular spindle cell tumour with wavy collagen bundles within myxoid stroma which is consistent with a neurofibroma. He was treated surgically and currently being followed up annually by the ENT department.

3. Discussion {#sec3}
=============

3.1. Discussion {#sec3.1}
---------------

Neurofibromas are benign, slow growing, and relatively circumscribed but nonencapsulated peripheral nerve sheath tumours arising from nonmyelinating Schwann cells \[[@B1]--[@B9]\]. They can arise as solitary tumours or multiple tumours as a component of neurofibromatosis \[[@B3], [@B7]--[@B11]\]. Neurofibromatosis is not a single entity, but a group of heterogeneous multisystemic neurocutaneous disorders involving both neuroectodermal and mesenchymal derivatives \[[@B15]\]. It is one of the most common hereditary diseases occurring in 1 of every 3000 births \[[@B19]\].

The National Institute of Health (NIH) has defined neurofibromatosis to two distinct types \[[@B16], [@B18]\]:Peripheral type (NF-I; von Recklinghausen\'s disease) is associated with changes in the long arm of chromosome number 17 and accounts for over 90% of cases. Major defining features include neurofibromas, cutaneous café au lait macules, and Lisch nodules (pigmented iris hamartomas).Central type (NF-II) is associated with a defect near the center of long arm of chromosome number 22 and is characterized by bilateral acoustic neuromas.

The World Health Organization (WHO) further classifies neurofibromas into dermal and plexiform. Dermal neurofibromas are located mainly in skin areas and composed of single peripheral nerve with soft pedunculated masses of skin in a form of bump. On the other hand, plexiform neurofibromas are composed of many nerve bundles and located mainly within subcutaneous area \[[@B6]\].

Neurofibromas of the nose and paranasal sinuses arise from the ophthalmic and maxillary division of the trigeminal nerve and autonomic plexuses \[[@B7], [@B10], [@B12]\]. At present there are only 29 reported cases in literature as shown in [Table 1](#tab1){ref-type="table"}, with only two reported bilateral solitary maxillary sinus neurofibromas and the youngest case being 5 months old \[[@B2], [@B4]\].

3.2. Sign and Symptoms {#sec3.2}
----------------------

Symptoms described by patients are nonspecific and depend heavily on the exact location and extension of the lesion \[[@B7], [@B11]\]. They are thus often clinically silent reaching considerable size in this location before diagnosis \[[@B11], [@B10], [@B12]\]. Advanced neurofibromas arising in the maxillary sinus cause pain, epistaxis, nasal obstruction, proptosis, and swelling of the face as described in this case \[[@B12], [@B8]\].

3.3. Imaging {#sec3.3}
------------

Imaging may not provide a definitive diagnosis; however it plays an important part in assessing, staging, operative planning, and monitoring of the progression of the disease \[[@B9]\].

CT scan may show heterogeneous soft tissue density and destruction of paranasal sinuses dependent on the stage of the disease \[[@B11]\]. Whereas MRI scan usually shows an isotense (lower intensity signal than gray matter) on T1-weighted images and hypertense (higher intensity signal than gray matter) on T2-weighted images \[[@B7], [@B9], [@B10], [@B12]\].

3.4. Immunohistochemistry {#sec3.4}
-------------------------

These lesions may be difficult to distinguish initially as their histology may be similar to other fibrous lesions such as juvenile fibromatosis or fibromyxoma in small biopsy or curettage specimens \[[@B12], [@B4]\]. Therefore biopsy should include an area of the lesion from deeper portions of the soft tissue swelling, sufficient for macroscopic and microscopic examination and immunohistochemical study \[[@B12], [@B4]\].

Histopathological examination of neurofibroma typically shows curve indent and ovoid Schwann cell nuclei with spindle cells, wavy nuclei, wavy collagen fibrils, and scatter mast cells embedded in an extended extracellular matrix \[[@B1], [@B7], [@B12], [@B13]\].

Whereas schwannomas show distinctive areas identified as Antoni types A and B, typical palisade pattern of nuclei, encapsulated, solitary, and tumour density is higher compared to neurofibromas, which usually show a mucoid extracellular matrix with only scatter tumour cells \[[@B9], [@B5]\].

In contrast, malignant peripheral nerve sheath tumours (PNST) are characterized by hypercellularity, "herringbone" fascicular growth pattern, atypical mitotic figures, and pleomorphic tumour cells and nuclei \[[@B13], [@B5]\].

Immunochemistry can further help to differentiate neurofibromas from schwannomas and malignant peripheral nerve sheath tumours. Neurofibromas show characteristic immunoreactivity with S-100, neurospecific enolase (NSE), and Vimentin \[[@B1], [@B3], [@B7], [@B11], [@B5]\].

However it is weak and shows focal to patchy reactivity to GFAP, SOX10, and bcl-2 \[[@B13]\].

Malignant PNST tend to show higher percentage of cells positivity and stronger intensity of staining \[[@B14]\].

Calretinin is a calcium-binding protein which is present in a diffuse and strong fashion in schwannoma; aiding the differentiation between neurofibroma and schwannoma as S-100 protein is positive in both tumours.

3.5. Differential Diagnosis {#sec3.5}
---------------------------

NF of the sinonasal tract is difficult and often misdiagnosed. Differential diagnoses in the order of frequency are shown as follows \[[@B17], [@B14]\].

Differential diagnosis of sinonasal tract neurofibroma (in order of frequency):SchwannomaDermatofibrosarcoma protuberansFibrosarcomaMeningiomaLeiomyomaSolitary fibrous tumourLeiomyosarcomaMalignant fibrous histiocytomaLow-grade sinonasal sarcoma with neural and myogenic featuresProliferative fasciitisInflammatory pseudotumourFibromatosisFibrous histiocytoma

3.6. Treatment {#sec3.6}
--------------

Peripheral nerve tumours are insensitive to radiotherapy and respond poorly to chemotherapy \[[@B9], [@B8]\]. Hence, early diagnosis and complete surgical excision are the gold standard treatment in symptomatic masses \[[@B1], [@B3], [@B7], [@B9], [@B5]\].

At present there is no consensus regarding the indication and optimal timing for resection. In general the tumour can be resected if surgery could be performed without risk of damaging vital structures and disfiguring the patient \[[@B9]\].

If surgical resection is not possible, patients are generally managed conservatively with close observation \[[@B9]\]. Although recurrence rate is low, there have been case reports of malignant transformation of these tumours. The transformation of neurofibroma into malignant peripheral nerve sheath tumour has been observed in 2--14% of cases of neurofibromatosis type 1, with a latency period of about 10--20 years. Thus a close followup is warranted \[[@B7], [@B9], [@B10], [@B4], [@B5], [@B20]\]. Pain, change in texture, rapid increase in size, and neurological deficits are indications of a malignant transformation within a preexisting neurofibroma \[[@B7], [@B9]\].

4. Conclusion {#sec4}
=============

Despite the rarity of this disease, otorhinolaryngologist should consider a possibility of neurofibroma of the paranasal sinuses.
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![Axial MRI showing lobulated mass in the right maxillary antrum extending anteriorly into the subcutaneous tissue of the cheek and posteriorly into the infratemporal fossa.](CRIPA2016-4294729.001){#fig1}

![Postgadolinium MRI coronal sequence showing superior extension into the right orbit.](CRIPA2016-4294729.002){#fig2}

###### 

Case reports on maxillary neurofibroma.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   Year   Author                                Age (year)   Gender    Site (maxilla)                                  Journal
  -------- ------ ------------------------------------- ------------ --------- ----------------------------------------------- ----------------------------------------------------------------------
  1        2016   Toms et al. \[[@B27]\]                n/a          n/a       Bilateral                                       Journal of Neurosurgery

  2        2015   Warhekar \[[@B18]\]                   22           Male      Left                                            Journal of Clinical and Diagnostic Research

  3        2014   Jain et al. \[[@B21]\]                65           Female    Right                                           Contemporary Clinical Dentistry

  4        2014   Azani et al. \[[@B13]\]               52\          Female\   Right\                                          Head and Neck Pathology\
                                                        33\          Female\   Right\                                          (case series)
                                                        34\          Male\     Left\                                           
                                                        66           Female    Left                                            

  5        2014   Adnane et al. \[[@B11]\]              14           Male      Left                                            Journal of Head and Neck Physicians and Surgeons

  6        2014   Prakash et al. \[[@B1]\]              60           Female    Right                                           Research in Otolaryngology

  7        2014   Komorski et al. \[[@B6]\]             79           Female    Left                                            Otolaryngologia Polska

  8        2013   Solomon et al. \[[@B3]\]              12           Female    Right                                           Innovative Journal of Medical and Health Science

  9        2012   Rokutanda et al. \[[@B12]\]           41           Male      Right                                           Journal of Oral and Maxillofacial Surgery, Medicine and Pathology

  10       2012   Dalili and Adham \[[@B17]\]           16           Male      Right                                           Iranian Journal of Radiology

  11       2011   Cegarra-Navarro et al. \[[@B10]\]     70           Female    Left                                            Acta Otorrinolaringol Esp

  12       2011   Biswas and Mal \[[@B23]\]             n/a          n/a       Bilateral                                       Ear, Nose and Throat Journal

  13       2011   Thammaiah et al. \[[@B15]\]           2.5          Female    Right                                           Journal of Paediatric Neurosciences

  14       2010   Dass et al. \[[@B5]\]                 25           Male      Right                                           Clinical Rhinology: An International Journal

  15       2010   Hachem et al. \[[@B9]\]               10           Female    Right                                           International Journal of Pediatric Otorhinolaryngology

  16       2009   Sharma et al. \[[@B4]\]               5 months     Male      Right                                           Journal of Indian Society of Pedodontics and Preventive Dentistry

  17       2009   Nao et al. \[[@B22]\]                 35           Female    Left                                            Annales d\'Otolaryngologie et de Chirurgie Cervico-Faciale

  18       2005   Boedeker et al. \[[@B7]\]             25           Male      Left                                            American Academy of Otolaryngology--Head and Neck Surgery Foundation

  19       1997   Poupard and Mintz \[[@B25]\]          n/a          n/a       Solitary neurofibroma of the maxilla            Journal of Oral Maxillofacial Surgery

  20       1993   Mori et al. \[[@B24]\]                n/a          n/a       Solitary intraosseous neurofibroma of maxilla   Journal of Oral and Maxillofacial Surgery

  21       1988   Tandon and Deka et al. \[[@B26]\]     n/a          n/a       Maxillary neurofibromas                         Indian Journal of Otolaryngology

  22       1988   Skouteris and Sotereanos \[[@B28]\]   n/a          n/a       n/a                                             Journal of Oral and Maxillofacial Surgery

  23       1982   Brady et al. \[[@B29]\]               n/a          n/a       n/a                                             Journal of Oral and Maxillofacial Surgery

  24       1980   Badger \[[@B30]\]                     n/a          n/a       n/a                                             Journal of the American Dental Association

  25       1979   Agarwal et al. \[[@B34]\]             n/a          n/a       n/a                                             Oral Surgery, Oral Medicine, Oral Pathology

  26       1975   Robitaille et al. \[[@B8]\]           45           Male      Right                                           American Society of Clinical Oncology\

  27       1975   Toth et al. \[[@B33]\]                n/a          n/a       n/a                                             Oral Surgery, Oral Medicine, Oral Pathology

  28       1970   De Costa et al. \[[@B31]\]            n/a          n/a       n/a                                             Hospital (Rio de Janeiro, Brazil)

  29       1965   Yamazaki et al. \[[@B32]\]            n/a          n/a       n/a                                             Jibi Inkoka Otolaryngology
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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